Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Postgraduate Medical Journal|October 28, 2006
What is the origin of ulcerative colitis? Still more questions than answersMilan Lukas, Martin Bortlik, Zdenek Maratka
Scandinavian Journal of Gastroenterology|July 15, 2020
Anti-SARS-CoV-2 antibody testing in IBD healthcare professionals: are we currently able to provide COVID-free IBD clinics?Karin Malickova, Zuzana Kratka, Stepanka Luxova, et al.
Journal of Crohn'S & Colitis|December 22, 2010
Non-adherence to treatment in inflammatory bowel disease in Czech RepublicPetr Cerveny, Martin Bortlik, Jirí Vlcek, et al.
European Journal of Gastroenterology & Hepatology|November 21, 2009
Anticarbohydrate antibodies as markers of inflammatory bowel disease in a Central European cohortKarin Malickova, Peter L Lakatos, Martin Bortlik, et al.
World Journal of Gastroenterology|June 29, 2006
Deficiency of Adenomatous Polyposis Coli protein in sporadic colorectal adenomas and its associations with clinical phenotype and histologyMartin Bortlik, Ivana Vitkova, Martina Papezova, et al.
Expert Review of Gastroenterology & Hepatology|December 20, 2022
Patient-reported symptoms are a more reliable predictor of the societal burden compared to established physician-reported activity indices in inflammatory bowel disease: a cross-sectional studyBarbora Decker, Jan Tuzil, Milan Lukas, et al.
Journal of Crohn'S & Colitis|December 4, 2012
Infliximab trough levels may predict sustained response to infliximab in patients with Crohn's diseaseMartin Bortlik, Dana Duricova, Karin Malickova, et al.
Inflammatory Bowel Diseases|November 4, 2009
Exogenous alkaline phosphatase for the treatment of patients with moderate to severe ulcerative colitisMilan Lukas, Pavel Drastich, Michal Konecny, et al.
Scandinavian Journal of Gastroenterology|July 10, 2013
Pregnancy and newborn outcome of mothers with inflammatory bowel diseases exposed to anti-TNF-α therapy during pregnancy: three-center studyMartin Bortlik, Nadezda Machkova, Dana Duricova, et al.
Dermatologic Therapy|June 7, 2014
Visceral leishmaniasis with cutaneous symptoms in a patient treated with infliximab followed by fatal consequencesKaterina Juzlova, Jana Votrubova, Denisa Kacerovska, et al.
Pageof 4